Skip to content

mRNA Manufacturing Raw Material Strategy After Capacity Shifts

mRNA manufacturing raw material strategy with IVT enzymes capping DNase cleanup and QC workflow

Recent mRNA manufacturing capacity shifts highlight why raw material strategy matters. This guide covers GMP-grade IVT enzymes, capping, DNase cleanup, QC and OEM planning for resilient RNA programs.

Residual DNA Testing for Gene Therapy Manufacturing: A Practical QC Guide

Residual DNA testing for gene therapy manufacturing practical QC guide with qPCR analysis, viral vector and DNA visualization

A practical guide to residual DNA testing in gene therapy and biomanufacturing QC, covering method selection, sample prep, HCP/HCD risk, and supplier considerations.

Meet Biori at BIO KOREA 2026 — Visit Booth L13

BIO KOREA 2026 Seoul event cover for Biori Booth L13 highlighting mRNA innovation, IVT enzymes, capping solutions and QC analytical solutions

Biori will attend BIO KOREA 2026 in Seoul from April 28–30. Visit us at Booth L13 to discuss IVD raw materials, PCR, NGS, IVT, OEM, and biopharma QC solutions.

mRNA Bird Flu Vaccine IVT Enzymes and QC Guide

mRNA bird flu vaccine IVT enzymes capping and quality control illustration

Explore the mRNA bird flu vaccine workflow, from GMP-grade IVT enzymes and capping to residual DNA and HCP testing for biopharma QC.